EJVES Vascular Forum最新文献

英文中文

The Role of Gender and of Systemic Immuno-Inflammation Index in Outcomes After Carotid Artery Stenting: The "Ge.Di.STENT.SII" Study In Precision Medicine for Cerebrovascular Disease 性别和全身免疫炎症指数在颈动脉支架置入术后结果中的作用：脑血管疾病精准医学 "Ge.Di.STENT.SII "研究

IF 1.4 Q3 PERIPHERAL VASCULAR DISEASE

EJVES Vascular Forum

Pub Date : 2024-01-01 DOI: 10.1016/j.ejvsvf.2024.07.022

G. Mastrangelo ∗ , A. Marzullo , P. Di Sebastiano , V. Palazzo

引用次数: 0

Ruptured Popliteal Artery Aneurysm: Is Endovascular Treatment A Valid Option? 腘动脉瘤破裂：血管内治疗是有效的选择吗？

IF 1.4 Q3 PERIPHERAL VASCULAR DISEASE

EJVES Vascular Forum

Pub Date : 2024-01-01 DOI: 10.1016/j.ejvsvf.2024.07.017

T. Cohnert ∗ , G. Siegl , N. Föger , S. Koter , A. Baumann

引用次数: 0

Comparison of Hospital Stay After Open Abdominal Aortic Aneurysm Repair With or Without Enhanced Recovery Protocol 采用或不采用增强恢复方案进行开放式腹主动脉瘤修复术后住院时间的比较

IF 1.4 Q3 PERIPHERAL VASCULAR DISEASE

EJVES Vascular Forum

Pub Date : 2024-01-01 DOI: 10.1016/j.ejvsvf.2024.10.004

Ilaria Peluttiero , Dimitrios Apostolou , Gianfranco Varetto , Lorenzo Gibello , Erica Mariani , Edoardo Frola , Fabio Barili , Matteo Ripepi , Massimo Maione , Fabio Verzini

Objective

Enhanced recovery after surgery (ERAS) is a protocol of evidence based practices applied in major surgery. Open aortic aneurysm repair is major surgery in terms of complications and mortality. This study aimed to compare early outcomes of ERAS with a traditional post-operative protocol in patients undergoing elective open aortic surgery.

Methods

This retrospective cohort study was conducted between 2018 – 2022 in two tertiary vascular surgery centres. The ERAS program was routinely implemented in one centre, while the other one used a standard peri-operative protocol. The primary outcome was post-operative length of stay (pLOS). Secondary outcomes were 30 day mortality rate, complications, re-interventions, and re-hospitalisations. Propensity score weighting was used to balance the two groups by comorbidities. Inverse probability of treatment weight (IPTW) was used to estimate the average treatment effect on the treated patients.

Results

A total of 198 patients were enrolled: 128 in the ERAS group (EG) and 70 in the standard group (SG). Mean age was 70.8 ± 6.7 years in EG and 71.1 ± 6.7 in SG (p = 0.39). No significant differences were observed in pre-operative cardiovascular risk factors. The median pLOS was 5 days (IQR 3, 6) in the EG group and 8 days (IQR 6, 11) in the SG group (p < 0.001). No differences in terms of mortality, re-operations, and re-hospitalisations were observed. The IPTW analyses showed a 40% reduction in pLOS and a significant reduction in major complications in EG (OR 0.41, 95% CI 0.26–0.66; p < 0.001). A 45% increase in pLOS in patients with chronic obstructive pulmonary disease was found in both groups.

Conclusion

Enhanced recovery after surgery is safe and feasible for elective open aortic surgery and is associated with earlier hospital discharge without differences in terms of mortality and lower complication rates compared with a standard protocol. Chronic obstructive pulmonary disease is a major risk factor for an increase in pLOS. The ERAS protocol is promising in terms of resource utilisation.

目的术后强化恢复（ERAS）是一项应用于大手术的循证实践方案。就并发症和死亡率而言，开腹主动脉瘤修补术是一项重大手术。本研究旨在比较ERAS与传统术后方案对择期接受开放式主动脉手术患者的早期疗效。方法这项回顾性队列研究于2018-2022年间在两家三级血管外科中心进行。其中一个中心常规实施ERAS计划，而另一个中心则采用标准围手术期方案。主要结果是术后住院时间（pLOS）。次要结果是 30 天死亡率、并发症、再次介入治疗和再次住院。采用倾向评分加权法来平衡两组患者的合并症。采用治疗权重逆概率（IPTW）估算治疗患者的平均治疗效果：ERAS组（EG）128人，标准组（SG）70人。EG 组的平均年龄为（70.8 ± 6.7）岁，SG 组为（71.1 ± 6.7）岁（P = 0.39）。术前心血管风险因素无明显差异。EG 组的中位 pLOS 为 5 天（IQR 3，6），SG 组为 8 天（IQR 6，11）（p < 0.001）。在死亡率、再次手术和再次住院方面没有观察到差异。IPTW 分析显示，EG 组的 pLOS 减少了 40%，主要并发症显著减少（OR 0.41，95% CI 0.26-0.66; p <0.001）。结论对于择期开放式主动脉手术而言，术后加强恢复是安全可行的，与标准方案相比，术后加强恢复可使患者更早出院，但在死亡率和并发症发生率方面并无差异。慢性阻塞性肺病是导致 pLOS 增加的主要风险因素。ERAS方案在资源利用方面很有前景。

{"title":"Comparison of Hospital Stay After Open Abdominal Aortic Aneurysm Repair With or Without Enhanced Recovery Protocol","authors":"Ilaria Peluttiero , Dimitrios Apostolou , Gianfranco Varetto , Lorenzo Gibello , Erica Mariani , Edoardo Frola , Fabio Barili , Matteo Ripepi , Massimo Maione , Fabio Verzini","doi":"10.1016/j.ejvsvf.2024.10.004","DOIUrl":"10.1016/j.ejvsvf.2024.10.004","url":null,"abstract":"<div><h3>Objective</h3><div>Enhanced recovery after surgery (ERAS) is a protocol of evidence based practices applied in major surgery. Open aortic aneurysm repair is major surgery in terms of complications and mortality. This study aimed to compare early outcomes of ERAS with a traditional post-operative protocol in patients undergoing elective open aortic surgery.</div></div><div><h3>Methods</h3><div>This retrospective cohort study was conducted between 2018 – 2022 in two tertiary vascular surgery centres. The ERAS program was routinely implemented in one centre, while the other one used a standard peri-operative protocol. The primary outcome was post-operative length of stay (pLOS). Secondary outcomes were 30 day mortality rate, complications, re-interventions, and re-hospitalisations. Propensity score weighting was used to balance the two groups by comorbidities. Inverse probability of treatment weight (IPTW) was used to estimate the average treatment effect on the treated patients.</div></div><div><h3>Results</h3><div>A total of 198 patients were enrolled: 128 in the ERAS group (EG) and 70 in the standard group (SG). Mean age was 70.8 ± 6.7 years in EG and 71.1 ± 6.7 in SG (<em>p</em> = 0.39). No significant differences were observed in pre-operative cardiovascular risk factors. The median pLOS was 5 days (IQR 3, 6) in the EG group and 8 days (IQR 6, 11) in the SG group (<em>p</em> < 0.001). No differences in terms of mortality, re-operations, and re-hospitalisations were observed. The IPTW analyses showed a 40% reduction in pLOS and a significant reduction in major complications in EG (OR 0.41, 95% CI 0.26–0.66; <em>p</em> < 0.001). A 45% increase in pLOS in patients with chronic obstructive pulmonary disease was found in both groups.</div></div><div><h3>Conclusion</h3><div>Enhanced recovery after surgery is safe and feasible for elective open aortic surgery and is associated with earlier hospital discharge without differences in terms of mortality and lower complication rates compared with a standard protocol. Chronic obstructive pulmonary disease is a major risk factor for an increase in pLOS. The ERAS protocol is promising in terms of resource utilisation.</div></div>","PeriodicalId":36502,"journal":{"name":"EJVES Vascular Forum","volume":"62 ","pages":"Pages 97-103"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142655166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Face, Content, and Construct Validity of a Low Cost and Open Source Endovascular Simulator 低成本开源血管内模拟器的表面、内容和结构有效性

IF 0.6 Q3 PERIPHERAL VASCULAR DISEASE

EJVES Vascular Forum

Pub Date : 2024-01-01 DOI: 10.1016/j.ejvsvf.2024.01.021

James Budge ∗ , Luis Ribero , Bilal Azhar , Iain Roy , Ian Loftus , Peter Holt

引用次数: 0

Aortic Seat Belt Injuries: Analysis of 52 Cases Published in the Last 60 Years 主动脉安全带损伤：对过去 60 年发表的 52 个病例的分析

IF 0.6 Q3 PERIPHERAL VASCULAR DISEASE

EJVES Vascular Forum

Pub Date : 2024-01-01 DOI: 10.1016/j.ejvsvf.2024.01.031

Eduardo Silva ∗ , Vânia Constâncio , Celso Nunes , Leonor Baldaia , Miguel Silva , Luís Orelhas , Manuel Fonseca

引用次数: 0

Time and Regional Trends in Hybrid Revascularisation for Patients With Lower Limb Ischaemia 下肢缺血患者混合血管重建手术的时间和地区趋势

IF 0.6 Q3 PERIPHERAL VASCULAR DISEASE

EJVES Vascular Forum

Pub Date : 2024-01-01 DOI: 10.1016/j.ejvsvf.2024.01.013

Shah Nawaz ∗ , Thaison Tong , Paul Brindley , Stephen Walters , Jonathon Michaels , Ravi Maheswaran

引用次数: 0

Open vs. Endovascular Revascularisation of Left Subclavian Artery in TEVAR: Systematic Review and Meta-Analysis TEVAR 中左锁骨下动脉开放血管再通术与血管内再通术的比较：系统性回顾与元分析

IF 0.6 Q3 PERIPHERAL VASCULAR DISEASE

EJVES Vascular Forum

Pub Date : 2024-01-01 DOI: 10.1016/j.ejvsvf.2024.01.048

Kadek Sulistyaningsih , Thomas Jatiman , Danang Himawan Limanto ∗

引用次数: 0

Potential Associations Between Abdominal Aortic Aneurysm, Smoking, and Air Pollution: A Data Visualisation Journey 腹主动脉瘤、吸烟和空气污染之间的潜在关联：数据可视化之旅

IF 0.6 Q3 PERIPHERAL VASCULAR DISEASE

EJVES Vascular Forum

Pub Date : 2024-01-01 DOI: 10.1016/j.ejvsvf.2024.01.010

Liam Musto ∗ , Athanasios Saratzis , Anna Hansell , Matthew Bown

引用次数: 0

Outcome of Single Stage Hybrid Revascularization for Multilevel Peripheral Arterial Disease 单段混合血管重建术治疗多发性外周动脉疾病的效果

IF 0.6 Q3 PERIPHERAL VASCULAR DISEASE

EJVES Vascular Forum

Pub Date : 2024-01-01 DOI: 10.1016/j.ejvsvf.2024.01.057

Baker Ghoneim ∗ , Prakash Madhavan , Sinead Cremen , Zenia Martin , Sean O'Neill , Adrian O'Callaghan , Catriona Canning , Mary Colgan (prof)

引用次数: 0

What Proportion of AAAs Detected in AAA Screening Might Be Identified in Lung Cancer Screening 在 AAA 筛查中发现的 AAA 在肺癌筛查中可能占多大比例

IF 0.6 Q3 PERIPHERAL VASCULAR DISEASE

EJVES Vascular Forum

Pub Date : 2024-01-01 DOI: 10.1016/j.ejvsvf.2024.01.046

Alireza Sherafat ∗ , Liam Musto , Ismail Rahman , Matt Bown

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

EJVES Vascular Forum

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀